Laboratorio Reig Jofre, S.A. (FEQ1.F)
Frankfurt · EUR · Healthcare · Drug Manufacturers - Specialty & Generic
€2.48 (-0.40%) as of
Key statistics
- Market cap
- 203.55M
- P/E (TTM)
- 31.00
- EPS (TTM)
- 0.0800
- Dividend yield
- 0.95%
- 52-week range
- 2.1300 – 2.9100
- Beta
- 0.94
- Revenue (TTM)
- 337.73M
- Profit margin
- 2.05%
- Volume
- 39.00
About Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women's health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Barcelona, Spain
- Employees
- 1,512
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.